Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Efisio, Puxeddu"'
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/0921f55573c24d0e8687a252cebb6458
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
Immune system plays a key role in cancer prevention as well as in its initiation and progression. During multistep development of tumors, cells must acquire the capability to evade immune destruction. Both in vitro and in vivo studies showed that thy
Externí odkaz:
https://doaj.org/article/b3a622aa4dd3453a9e23a69cd79d0bb0
Autor:
Giuseppe Mollica, Daniela Francesconi, Gabriele Costante, Sonia Moretti, Riccardo Giannini, Efisio Puxeddu, Paolo Valigi
Publikováno v:
IFAC-PapersOnLine. 55:67-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23937fb0c7a725e3414a9a4e2e3034fc
https://doi.org/10.1016/j.ifacol.2023.01.050
https://doi.org/10.1016/j.ifacol.2023.01.050
Autor:
Giorgio Grani, Michele Gentili, Federico Siciliano, Domenico Albano, Valentina Zilioli, Silvia Morelli, Efisio Puxeddu, Maria Chiara Zatelli, Irene Gagliardi, Alessandro Piovesan, Alice Nervo, Umberto Crocetti, Michela Massa, Maria Teresa Samà, Chiara Mele, Maurilio Deandrea, Laura Fugazzola, Barbara Puligheddu, Alessandro Antonelli, Ruth Rossetto, Annamaria D’Amore, Graziano Ceresini, Roberto Castello, Erica Solaroli, Marco Centanni, Salvatore Monti, Flavia Magri, Rocco Bruno, Clotilde Sparano, Luciano Pezzullo, Anna Crescenzi, Caterina Mian, Dario Tumino, Andrea Repaci, Maria Grazia Castagna, Vincenzo Triggiani, Tommaso Porcelli, Domenico Meringolo, Laura Locati, Giovanna Spiazzi, Giulia Di Dalmazi, Aris Anagnostopoulos, Stefano Leonardi, Sebastiano Filetti, Cosimo Durante
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
ContextThe risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in clinical decision making. The most widely accepted method to assess risk of recurrent/persistent disease is described in the 2015 American Thyroid Assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74498f7aca4cd8f96543c512aad2a978
https://doi.org/10.1210/clinem/dgad075
https://doi.org/10.1210/clinem/dgad075
Autor:
Cinzia Antognelli, Sonia Moretti, Roberta Frosini, Efisio Puxeddu, Angelo Sidoni, Vincenzo N. Talesa
Publikováno v:
Cells, Vol 8, Iss 6, p 547 (2019)
Methylglyoxal (MG) is a potent inducer of advanced glycation end products (AGEs). MG, long considered a highly cytotoxic molecule with potential anticancer value, is now being re-evaluated to a protumorigenic agent in some malignancies. Anaplastic th
Externí odkaz:
https://doaj.org/article/196380adcf8e4888a659603a318541b3
Autor:
Elisa Bianconi, Alessandra Riccio, Luana Ruta, Carlo Bigiotti, Andrea Carotti, Sonia Moretti, Bruno Cerra, Antimo Gioiello, Simone Ferlin, Efisio Puxeddu, Antonio Macchiarulo
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 6; Pages: 5535
PD-1/PD-L1 protein complex is attracting a great deal of interest as a drug target for the design of immune therapies able to block its assembly. Although some biologic drugs have entered clinical use, their poor response rate in patients are demandi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a760962dd24f8c986149ea5de155a22
https://doi.org/10.3390/ijms24065535
https://doi.org/10.3390/ijms24065535
Autor:
Elisa Menicali, Nicole Nucci, Efisio Puxeddu, Martina Guzzetti, Sonia Moretti, Silvia Morelli
Publikováno v:
European Journal of Endocrinology. 183:R41-R55
Immunotherapy has arisen in use in the field of oncology with seven immune checkpoint inhibitors approved for the treatment of a variety of cancer histologies. Depending on the cancer type, the success rate might be different, but in average it is ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd22e54cb8e6089264917e2e33aca2f
https://doi.org/10.1530/eje-20-0283
https://doi.org/10.1530/eje-20-0283
Autor:
Gioia Fiorucci, Efisio Puxeddu, Renato Colella, Gian Paolo Reboldi, Vincenzo Villanacci, Gabrio Bassotti
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 2, Pp 142-144 (2014)
Villous atrophy and negative serologic testing is a diagnostic challenge, and the rarer possibility of drug-induced enteritis should be considered. We report a rare case of severe spruelike enteritis due to olmesartan that completely resolved after w
Externí odkaz:
https://doaj.org/article/a49e85e600b440dd8ce7762853a46aef
Autor:
Barbara Puligheddu, Loredana Pagano, Sebastiano Filetti, Giovanni Tallini, Giovanna Spiazzi, Andrea Repaci, Valentina Zilioli, Giorgio Grani, Silvia Morelli, Umberto Ferraro Petrillo, Dario Tumino, Luciano Pezzullo, Alberto Ragni, Efisio Puxeddu, Marco Alfò, Marco Centanni, Laura Fugazzola, R. Rossetto, Maria Grazia Castagna, Raffaele Giubbini, Clotilde Sparano, Anna Crescenzi, Raffaella Forleo, Massimo Torlontano, Celestino Pio Lombardi, Maurilio Deandrea, Alessandro Piovesan, Cosimo Durante, Fabio Monzani, Alessandro Antonelli, Rocco Bruno, Salvatore Monti, Maria Chiara Zatelli, Irene Gagliardi, Graziano Ceresini
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 31(12)
Background: The role of minimal extrathyroidal extension (mETE) as a risk factor for persistent papillary thyroid carcinoma (PTC) is still debated. The aim of this study was to assess the clinical impact of mETE as a predictor of worse initial treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8715aa58429e753bc54b287a22a2077f
https://pubmed.ncbi.nlm.nih.gov/34541894
https://pubmed.ncbi.nlm.nih.gov/34541894
Autor:
Renato Colella, Angelo Sidoni, Sonia Moretti, Jacopo Vannucci, Francesco Puma, Guido Bellezza, Nicola Avenia, Andrea Polistena, Massimo Monacelli, Efisio Puxeddu, Marco Andolfi, Martina Mandarano, Alessandro Sanguinetti
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 4351, p 4351 (2021)
Volume 10
Issue 19
Journal of Clinical Medicine, Vol 10, Iss 4351, p 4351 (2021)
Volume 10
Issue 19
Primary thyroid tumours show different levels of aggressiveness, from indolent to rapidly growing infiltrating malignancies. The most effective therapeutic option is surgery when radical resection is feasible. Biomarkers of aggressiveness may help in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb88d6c48e9878dd849bd6a343203fa
http://europepmc.org/articles/PMC8509765
http://europepmc.org/articles/PMC8509765